01Clinical context
What is the finding?
A suspicious pigmented lesion requires diagnostic assessment and exclusion of malignancy before any aesthetic procedure.
Melasma and Pigmentation Disorders · Medical Skin Care · Istanbul
Melasma and Pigmentation Disorders · Medical Skin Care · Istanbul
Melasma and Pigmentation Disorders
Melasma, solar lentigo, post-inflammatory hyperpigmentation, freckles and medicine- or hormone-related pigment change are not interchangeable diagnoses. A named care method, ingredient or infusion is not a diagnosis and does not establish personal suitability.
Online information cannot diagnose, select products or procedures, or promise an outcome. Final decisions require an in-person medical assessment.
Clinical Orientation
Finding · identity · evidence · safety
Four questions precede a personal plan.
The sequence prevents a category name from becoming an automatic treatment recommendation.
02Identity
What exactly is proposed?
Photoprotection, trigger management, topical care, peels and device options have different roles and risks.
03Evidence
What does the evidence support?
Melasma may relapse or flare; no product, peel or laser removes every pigmentation disorder.
04Safety
When should it stop?
Stop and arrange assessment for a changing or bleeding lesion, severe irritation, blistering, delayed healing or marked colour change.
What are Melasma & Pigmentation Disorders?
Melasma · PIH · Lentigo · Differential diagnosis
Pigmentation disorder is an umbrella term — melasma is a specific pattern.
Melasma usually presents as flat, bilateral brown or grey-brown areas on light-exposed regions. Pigmentation disorders have many causes; not every brown mark is melasma.
What Melasma & Pigmentation assessment can do
- Combine symmetry, distribution, colour and time course as diagnostic clues
- Record UV and visible-light exposure together with hormonal or inflammatory triggers
- Stage topical agents, maintenance and, where appropriate, procedures sensibly
- Monitor change with standardised photographs under comparable lighting
What Melasma & Pigmentation treatment cannot do
- Lighten a new or changing individual lesion cosmetically without a diagnosis
- Cure melasma permanently or guarantee a relapse-free course
- Treat every brown mark with the same laser, peel or active ingredient
- Replace daily photoprotection with a more intensive treatment session
Asymmetry, rapid change, elevation, bleeding or a conspicuous individual structure first require dermatological assessment. Cosmetic lightening must not delay diagnosis.
Medical Suitability
Diagnosis and activity before care
Five checks come before selection.
History, examination, current treatment, contraindications and a proportionate alternative are reviewed together.
- 01
Clarify the problem
A suspicious pigmented lesion requires diagnostic assessment and exclusion of malignancy before any aesthetic procedure.
- 02
Review current treatment
Medicines, allergies, previous procedures or infusions and relevant reactions are considered.
- 03
Identify the exact option
Photoprotection, trigger management, topical care, peels and device options have different roles and risks.
- 04
Compare alternatives
Photoprotection, trigger review, diagnosis-led topical care, observation, dermatology assessment or no procedure
- 05
Plan follow-up
Stop and arrange assessment for a changing or bleeding lesion, severe irritation, blistering, delayed healing or marked colour change.
Care Path
Before · during · after
Safety depends on a complete, documented chain.
Photoprotection, trigger management, topical care, peels and device options have different roles and risks.
01Before
Confirm finding and skin state
A suspicious pigmented lesion requires diagnostic assessment and exclusion of malignancy before any aesthetic procedure.
- Review history and examination
- Check contraindications
- Keep alternatives open
02During
Control exposure and response
Photoprotection, trigger management, topical care, peels and device options have different roles and risks.
- Maintain traceability
- Monitor tolerance
- Stop when safety changes
03After
Separate expected response from harm
Stop and arrange assessment for a changing or bleeding lesion, severe irritation, blistering, delayed healing or marked colour change.
- Record observations
- Explain warning signs
- Provide a review route
No personal acid concentration, contact time, prescription medicine or home-treatment recipe is published.
Evidence and Limits
Method-, product- and indication-specific
Biology or popularity is not proof of clinical benefit.
Melasma may relapse or flare; no product, peel or laser removes every pigmentation disorder.
Keep the indication exact
Evidence in one diagnosis or deficiency does not establish a general effect.
Keep the intervention exact
Photoprotection, trigger management, topical care, peels and device options have different roles and risks.
Keep endpoints separate
Symptoms, photographs, laboratory values and patient-reported outcomes are not interchangeable.
Retain uncertainty
Pigment clearance and freedom from recurrence cannot be guaranteed.
Manufacturer information may identify a product and instructions, but it is not treated as independent evidence of a general class effect.
Individual Plan
Light control before treatment intensity
The plan begins with light control.
Triggers and photoprotection are stabilised first; a tolerable active ingredient follows, with an addition only if needed.
Confirm the diagnosis
Separate melasma, PIH, lentigo and conspicuous individual lesions.
Stabilise photoprotection
Address UVA, UVB and visible light consistently in daily life.
Review the topical phase
Start a suitable active ingredient within a clear tolerance limit.
Set maintenance
Continue protection, care and review points after lightening.
Course and Follow-Up
Expected response · complication · reassessment
Repetition is never automatic.
Tolerance and the agreed clinical endpoint are reviewed separately before any further intervention.
- 01Before
Baseline
Record the starting clinical context and intended endpoint.
- 02Same day
Immediate review
Observe tolerance and unexpected reactions.
- 03Later
Clinical review
Compare the relevant finding without automatic attribution.
- 04Decision
Continue, change or stop
Stop and arrange assessment for a changing or bleeding lesion, severe irritation, blistering, delayed healing or marked colour change.
Risks and Alternatives
Avoid misdiagnosis and overtreatment
Lightening can also change pigmentation permanently.
Possible harms include irritant or allergic dermatitis, PIH, hypopigmentation, paradoxical darkening, scars, uneven colour and relapse; pregnancy changes active-ingredient selection.
01Diagnosis
Clarify an individual lesion first
New, asymmetrical, raised, bleeding or rapidly changing marks are not treated cosmetically.
02Safety
Consider pregnancy
Hydroquinone, retinoids and other active ingredients require their own safety review.
03Medicine
Review systemic risks
Oral tranexamic acid is considered only after medical review of contraindications and thrombosis risk.
04Procedure
Limit procedural risk
Peels and lasers can intensify pigment, cause uneven lightening or produce scars.
Bleeding, ulceration, rapid change or a conspicuous individual lesion need timely dermatological diagnosis. Remote assessment must not replace that evaluation.
Istanbul and Follow-Up
Assessment and review must travel together
International care needs a workable safety route.
Travel does not shorten observation or remove the need for local medical access.
01
Organise the question
History and existing records prepare discussion without confirming treatment.
02
Assess in person
A suspicious pigmented lesion requires diagnostic assessment and exclusion of malignancy before any aesthetic procedure.
03
Keep exact records
Photoprotection, trigger management, topical care, peels and device options have different roles and risks.
04
Plan escalation
Stop and arrange assessment for a changing or bleeding lesion, severe irritation, blistering, delayed healing or marked colour change.
The Doctor Aslan Approach
Medical position
Pigment control needs patience, not maximum intensity.
Dr İsmail Aslan does not automatically treat a colour change as melasma. Diagnosis, light response, phototype, pregnancy, previous PIH and long-term practicality determine how cautiously treatment begins.
Diagnosis before colour
The pattern and any individual lesion determine whether lightening is the right step at all.
Photoprotection as the foundation
An active-ingredient plan without practical UV and visible-light protection remains incomplete.
Low irritation before intensity
A stable, tolerable foundation takes priority over combining several procedures too quickly.
Maintenance before relapse
The aim is controlled pigmentation with a clear long-term strategy, not one temporarily lighter photograph.
Medical responsibility: Dr İsmail AslanMedical review: 24 August 2026General patient information about Melasma and Pigmentation Disorders; no personal prescription or outcome guarantee
Frequently Asked Questions
Short and clear
Questions commonly asked before a decision.
These answers provide general orientation and do not replace personal diagnosis or treatment planning.
01How does melasma differ from other brown marks?+
Melasma typically presents as flat, often symmetrical brown or grey-brown areas on light-exposed facial regions. Post-inflammatory hyperpigmentation follows inflammation; lentigines and medicine-related changes have different patterns. A new, asymmetric, raised, bleeding or rapidly changing individual mark needs its own diagnosis before any lightening treatment.
02Why may tinted sunscreen with iron oxides be useful for melasma?+
Broad-spectrum sunscreen addresses UVA and UVB. Visible light can also aggravate melasma, especially in darker skin tones; iron oxides in tinted sunscreen add protection here. An appropriate shade, sufficient amount, reapplication, shade and a broad-brimmed hat remain important.
03Can laser or peeling remove melasma permanently?+
A permanent cure cannot be promised. Melasma tends to recur, and invasive procedures may cause PIH, hypopigmentation or renewed darkening depending on skin type, settings and inflammatory response. Laser or peeling is considered only as a justified addition to diagnosis, photoprotection, topical foundation and a maintenance plan.
04How is pigmentation treatment planned for travel to Istanbul?+
Photographs from different seasons, onset, pregnancies, hormones, medicines, light exposure, and previous active ingredients or procedures can be organised online. Diagnosis and suitability are determined in person; product access at home, visible reaction, return travel, photoprotection, review photographs and a local dermatology contact are clarified in advance.
Next Step
Define the question · verify the option · compare alternatives